JP2017153484A5 - - Google Patents

Download PDF

Info

Publication number
JP2017153484A5
JP2017153484A5 JP2017096499A JP2017096499A JP2017153484A5 JP 2017153484 A5 JP2017153484 A5 JP 2017153484A5 JP 2017096499 A JP2017096499 A JP 2017096499A JP 2017096499 A JP2017096499 A JP 2017096499A JP 2017153484 A5 JP2017153484 A5 JP 2017153484A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequences
capsid proteins
consensus sequence
circulating strains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017096499A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017153484A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017153484A publication Critical patent/JP2017153484A/ja
Publication of JP2017153484A5 publication Critical patent/JP2017153484A5/ja
Pending legal-status Critical Current

Links

JP2017096499A 2008-08-08 2017-05-15 交差反応性の増強のための複合カプシドアミノ酸配列を含むウイルス様粒子 Pending JP2017153484A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8750408P 2008-08-08 2008-08-08
US61/087,504 2008-08-08
US21860309P 2009-06-19 2009-06-19
US61/218,603 2009-06-19

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015075955A Division JP6448445B2 (ja) 2008-08-08 2015-04-02 交差反応性の増強のための複合カプシドアミノ酸配列を含むウイルス様粒子

Publications (2)

Publication Number Publication Date
JP2017153484A JP2017153484A (ja) 2017-09-07
JP2017153484A5 true JP2017153484A5 (cg-RX-API-DMAC7.html) 2018-02-22

Family

ID=41664003

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2011522301A Active JP5852883B2 (ja) 2008-08-08 2009-08-10 交差反応性の増強のための複合カプシドアミノ酸配列を含むウイルス様粒子
JP2015075955A Active JP6448445B2 (ja) 2008-08-08 2015-04-02 交差反応性の増強のための複合カプシドアミノ酸配列を含むウイルス様粒子
JP2017096499A Pending JP2017153484A (ja) 2008-08-08 2017-05-15 交差反応性の増強のための複合カプシドアミノ酸配列を含むウイルス様粒子

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2011522301A Active JP5852883B2 (ja) 2008-08-08 2009-08-10 交差反応性の増強のための複合カプシドアミノ酸配列を含むウイルス様粒子
JP2015075955A Active JP6448445B2 (ja) 2008-08-08 2015-04-02 交差反応性の増強のための複合カプシドアミノ酸配列を含むウイルス様粒子

Country Status (14)

Country Link
US (2) US8841120B2 (cg-RX-API-DMAC7.html)
EP (2) EP2324113B8 (cg-RX-API-DMAC7.html)
JP (3) JP5852883B2 (cg-RX-API-DMAC7.html)
KR (2) KR101793161B1 (cg-RX-API-DMAC7.html)
CN (2) CN104911154A (cg-RX-API-DMAC7.html)
AU (1) AU2009279456B2 (cg-RX-API-DMAC7.html)
CA (1) CA2733589C (cg-RX-API-DMAC7.html)
DK (1) DK2324113T3 (cg-RX-API-DMAC7.html)
ES (1) ES2668836T3 (cg-RX-API-DMAC7.html)
HK (1) HK1215051A1 (cg-RX-API-DMAC7.html)
NO (1) NO2324113T3 (cg-RX-API-DMAC7.html)
PL (1) PL2324113T3 (cg-RX-API-DMAC7.html)
SG (1) SG2013057732A (cg-RX-API-DMAC7.html)
WO (1) WO2010017542A1 (cg-RX-API-DMAC7.html)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9439959B2 (en) * 2006-07-27 2016-09-13 Takeda Vaccines, Inc. Chimeric influenza virus-like particles
EP2601970B1 (en) 2006-09-29 2016-10-26 Takeda Vaccines, Inc. Norovirus vaccine formulations
AU2008302276B2 (en) 2006-09-29 2013-10-10 Takeda Vaccines, Inc. Method of conferring a protective immune response to norovirus
KR101576219B1 (ko) * 2007-03-14 2015-12-10 다케다 백신즈 인코포레이티드 바이러스 유사 입자 정제
US20100266636A1 (en) 2007-09-18 2010-10-21 Ligocyte Pharmaceuticals, Inc. Method of conferring a protective immune response to norovirus
SG2013057732A (en) 2008-08-08 2015-02-27 Ligocyte Pharmaceuticals Inc Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
US10130697B2 (en) 2010-03-23 2018-11-20 Wisconsin Alumni Research Foundation (Warf) Vaccines comprising mutant attenuated influenza viruses
US20130171185A1 (en) * 2010-07-06 2013-07-04 Ethan Settembre Norovirus derived immunogenic compositions and methods
BR112014000656A2 (pt) 2011-07-11 2017-02-14 Takeda Vaccines Inc formulações de vacina parenteral contra norovírus
EP2747778B1 (en) 2011-08-26 2017-12-06 Wisconsin Alumni Research Foundation Influenza viruses with mutant pb2 gene segment as live attenuated vaccines
JP6567824B2 (ja) * 2011-10-12 2019-08-28 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア ヒトパピローマウイルスのワクチンおよびその使用方法
JOP20130186B1 (ar) 2012-06-22 2021-08-17 Takeda Vaccines Montana Inc تنقية الجزيئات الشبيهة بالفيروسات
AU2014248535B2 (en) 2013-03-12 2017-03-30 Inovio Pharmaceuticals, Inc. Improved vaccines for human papilloma virus and methods for using the same
JP6479305B2 (ja) 2013-07-12 2019-03-06 株式会社Ｕｍｎファーマ ウイルス様粒子の精製方法
JP2015015931A (ja) 2013-07-12 2015-01-29 株式会社Ｕｍｎファーマ ウイルス様粒子を含む培養物の製造方法
US10524493B2 (en) * 2013-09-16 2020-01-07 The Johns Hopkins University Compositions and methods for preventing or relieving symptoms of infections
EP3052631B1 (en) 2013-10-03 2019-08-07 Takeda Vaccines, Inc. Methods of detection and removal of rhabdoviruses from cell lines
KR20160091350A (ko) 2013-11-29 2016-08-02 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 중동 호흡기 증후군 코로나바이러스(MERS-CoV) 백신
WO2015196150A2 (en) 2014-06-20 2015-12-23 Wisconsin Alumni Research Foundation (Warf) Mutations that confer genetic stability to additional genes in influenza viruses
EP3341019A4 (en) * 2015-08-28 2019-07-31 Ology Bioservices, Inc. NOROVIRUS VACCINE
JP2018530314A (ja) 2015-08-28 2018-10-18 ウィスコンシン アルムニ リサーチ ファンデイション ウイルス様粒子からの感染性インフルエンザウイルスの生成
WO2017092711A1 (zh) * 2015-12-04 2017-06-08 厦门大学 一种人乳头瘤病毒11型l1蛋白的突变体
EP3417056A1 (en) 2016-02-19 2018-12-26 Wisconsin Alumni Research Foundation (WARF) Improved influenza b virus replication for vaccine development
CN110073005A (zh) * 2016-06-03 2019-07-30 奎斯特诊断投资有限责任公司 检测诺如病毒的方法
US11608361B2 (en) 2017-03-23 2023-03-21 Medicago Inc. Norovirus fusion proteins and VLPS comprising norovirus fusion proteins
TWI743346B (zh) 2017-03-31 2021-10-21 國立大學法人東京大學 諾羅病毒抗體
JP6795468B2 (ja) * 2017-07-14 2020-12-02 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア ヒトパピローマウイルスのワクチンおよびその使用方法
WO2019079594A1 (en) * 2017-10-18 2019-04-25 The University Of North Carolina At Chapel Hill METHODS AND COMPOSITIONS FOR VACCINES AGAINST NOVOVIRUS AND DIAGNOSIS OF NOVOVIRUS
JP2021500891A (ja) 2017-10-25 2021-01-14 ウィスコンシン アルムニ リサーチ ファンデイション 卵における複製のための安定化されたｈａを有する組換えインフルエンザウイルス
CN109776657B (zh) * 2017-11-14 2021-11-26 北京康乐卫士生物技术股份有限公司 重组诺如病毒vlp颗粒和制备方法及其用途
CN111727255A (zh) * 2017-11-30 2020-09-29 麦迪卡格公司 修饰后诺如病毒vp1蛋白和包含修饰后诺如病毒vp1蛋白的vlp
US11918646B2 (en) 2017-12-11 2024-03-05 Board Of Regents, The University Of Texas System Dry adjuvanted immune stimulating compositions and use thereof for mucosal administration
WO2019233415A1 (zh) * 2018-06-04 2019-12-12 厦门大学 一种人乳头瘤病毒39型l1蛋白的突变体
KR102075393B1 (ko) * 2018-06-28 2020-02-11 한국과학기술원 중증 열성 혈소판 감소 증후군(sfts) 바이러스 감염 질환 예방 또는 치료용 백신 조성물
US11759512B2 (en) 2018-07-13 2023-09-19 Medicago Inc. Modified norovirus VP1 proteins and VLPs comprising modified norovirus VP1 proteins
US12343390B2 (en) 2018-08-07 2025-07-01 Wisconsin Alumni Research Foundation (Warf) Recombinant biologically contained filovirus vaccine
US20210308249A1 (en) 2018-08-20 2021-10-07 Takeda Vaccines, Inc. Vlp formulations
US11389523B2 (en) 2018-08-20 2022-07-19 Wisconsin Alumni Research Foundation (Warf) Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (HA) protein
AR117462A1 (es) * 2018-12-20 2021-08-04 Takeda Vaccines Inc Vacuna contra norovirus, formulaciones y métodos
EP3921413A1 (en) 2019-02-08 2021-12-15 Wisconsin Alumni Research Foundation (WARF) Humanized cell line
CN114929269A (zh) 2019-05-01 2022-08-19 威斯康星校友研究基金会(Warf) 用于疫苗开发的改进的流感病毒复制
WO2021041624A2 (en) 2019-08-27 2021-03-04 Yoshihiro Kawaoka Recombinant influenza viruses with stabilized ha for replication in eggs
JP7075130B2 (ja) * 2019-10-25 2022-05-25 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア ヒトパピローマウイルスのワクチンおよびその使用方法
US11739303B2 (en) 2020-01-24 2023-08-29 Wisconsin Alumni Research Foundation (Warf) Recombinant influenza viruses with stabilized NA
WO2021195410A1 (en) 2020-03-25 2021-09-30 Wisconsin Alumni Research Foundation (Warf) Recombinant multivalent influenza viruses
CN114316033A (zh) * 2020-09-29 2022-04-12 香港理工大学深圳研究院 一种特异性识别诺如病毒的单克隆抗体及制备方法与应用
US20240066112A1 (en) * 2020-12-30 2024-02-29 Grand Theravac Life Science (Nanjing) Co., Ltd. Norovirus virus-like particle, immune composition, or kit, and use thereof
WO2022244860A1 (ja) * 2021-05-20 2022-11-24 デンカ株式会社 抗ノロウイルス抗体
EP4340874A1 (en) 2021-05-21 2024-03-27 Takeda Vaccines, Inc. Solid composition, freeze-drying method and glass vial
WO2023060086A1 (en) 2021-10-04 2023-04-13 Takeda Vaccines, Inc. Methods for determining norovirus-reactive antibodies
US20250205328A1 (en) * 2022-03-25 2025-06-26 Merck Sharp & Dohme Llc Controlled release vaccine formulations

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6572862B1 (en) 1989-11-08 2003-06-03 Baylor College Of Medicine Methods and reagents to detect and characterize Norwalk and related viruses
AU1893592A (en) 1991-03-25 1992-10-21 Board Of Trustees Of The Leland Stanford Junior University Norwalk virus human gastroenteritis agent and molecular cloning of corresponding cdnas
JPH07509122A (ja) * 1992-04-08 1995-10-12 ザ　ガバメント　オブ　ザ　ユナイテッド　ステイツ　オブ　アメリカ，アズ　レプリゼンテッド　バイ　ザ　セクレター，デパートメント　オブ　ヘルス　アンド　ヒューマン　サービシーズ 野生型麻疹ウイルス糖タンパク質：ワクチンおよびその検出方法
WO1994005700A2 (en) 1992-09-07 1994-03-17 Baylor College Of Medicine Methods and reagents to detect and characterize norwalk and related viruses
US5788970A (en) * 1994-03-29 1998-08-04 The University Of Maryland College Park Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
CA2189882C (en) * 1994-05-16 2005-09-20 Kathrin U. Jansen Papillomavirus vaccines
US5645051A (en) 1995-04-21 1997-07-08 Dura Pharmaceuticals, Inc. Unit dose dry powder inhaler
US5861241A (en) 1995-08-16 1999-01-19 University Of Massachusetts Monoclonal antibodies for detecting Norwalk virus
GB9525083D0 (en) 1995-12-07 1996-02-07 Danbiosyst Uk Vaccine compositions
US5953727A (en) * 1996-10-10 1999-09-14 Incyte Pharmaceuticals, Inc. Project-based full-length biomolecular sequence database
US6491919B2 (en) 1997-04-01 2002-12-10 Corixa Corporation Aqueous immunologic adjuvant compostions of monophosphoryl lipid A
JP2002508748A (ja) * 1997-05-01 2002-03-19 カイロン コーポレイション アジュバントとしてのウイルス様粒子の使用
US20040265377A1 (en) 1997-10-27 2004-12-30 Harry Seager Solid dispersing vaccine composition for oral delivery
EA200100236A1 (ru) 1998-08-14 2001-08-27 Мерк Энд Ко., Инк. Способ очистки вирусных частиц, подобных вирусу папилломы человека
ATE323508T1 (de) 1998-12-17 2006-05-15 Merck & Co Inc Synthetische virus-ähnliche partikel mit heterologen epitopen.
US7067638B1 (en) 1999-06-22 2006-06-27 Japan As Represented By Director-General National Institute Of Infectious Diseases Small round structured virus (SRSV) detection kit
JP2002020399A (ja) 2000-07-10 2002-01-23 Osaka Prefecture ノルウォークウイルス（ｎｖ）を認識するモノクローナル抗体
AU2003213060A1 (en) 2002-02-14 2003-09-04 Novavax, Inc. Optimization of gene sequences of chimeric virus-like particles for expression in insect cells
DE60335186D1 (de) * 2002-06-20 2011-01-13 Cytos Biotechnology Ag Verpackte virusartige partikel in kombination mit cpg zur verwendung als adjuvantien mit allergenen. herstellungsverfahren und verwendung
US7879338B2 (en) 2003-07-21 2011-02-01 Boyce Thompson Institute For Plant Research Vectors and methods for immunization against norovirus using transgenic plants
EP1670824A2 (en) 2003-09-24 2006-06-21 Montana State University Norovirus monoclonal antibodies and peptides
US7795242B2 (en) 2003-10-15 2010-09-14 The Brigham And Women's Hospital, Inc. Methods and compositions for immunomodulation
US20050215501A1 (en) 2003-10-24 2005-09-29 Coley Pharmaceutical Group, Inc. Methods and products for enhancing epitope spreading
FR2863890B1 (fr) 2003-12-19 2006-03-24 Aventis Pasteur Composition immunostimulante
US7481997B1 (en) * 2004-02-12 2009-01-27 Montana State University Snow mountain virus genome sequence, virus-like particles and methods of use
US20050260225A1 (en) 2004-05-18 2005-11-24 Goldberg Joanna B Intranasal recombinant Salmonella vaccine encoding heterologous polysaccharide antigens
CU23496A1 (es) * 2004-09-03 2010-02-23 Ct Ingenieria Genetica Biotech Composición vacunal contra el virus de la hepatitis c
SG156666A1 (en) 2004-10-20 2009-11-26 Acambis Inc Vaccines against japanese encephalitis virus and west nile virus
GB0428394D0 (en) 2004-12-24 2005-02-02 Chiron Srl Saccharide conjugate vaccines
EP1846439A2 (en) * 2005-01-31 2007-10-24 The Johns Hopkins University Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants
NZ560929A (en) 2005-02-18 2009-12-24 Novartis Vaccines & Diagnostic Immunogens from uropathogenic escherichia coli
US7767212B2 (en) 2005-03-18 2010-08-03 Cytos Biotechnology Ag CAT allergen conjugates and uses thereof
EP1736538A1 (en) 2005-06-21 2006-12-27 Cytos Biotechnology AG Process for the preparative purification of virus-like-particles (VLPs)
JP4825958B2 (ja) * 2005-08-10 2011-11-30 財団法人ヒューマンサイエンス振興財団 高リスク群ヒトパピローマウイルスの中和抗体を誘導する抗原
JP5215865B2 (ja) * 2005-11-22 2013-06-19 ノバルティス ヴァクシンズ アンド ダイアグノスティクス インコーポレイテッド ノロウイルス抗原およびサポウイルス抗原
JP2007145775A (ja) * 2005-11-29 2007-06-14 Falco Life Science:Kk ノロウイルスｇｉの高感度検出方法
EP2601970B1 (en) 2006-09-29 2016-10-26 Takeda Vaccines, Inc. Norovirus vaccine formulations
AU2008302276B2 (en) 2006-09-29 2013-10-10 Takeda Vaccines, Inc. Method of conferring a protective immune response to norovirus
US20100266636A1 (en) 2007-09-18 2010-10-21 Ligocyte Pharmaceuticals, Inc. Method of conferring a protective immune response to norovirus
SG2013057732A (en) * 2008-08-08 2015-02-27 Ligocyte Pharmaceuticals Inc Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
AU2011207355B2 (en) * 2010-01-21 2015-04-02 Takeda Vaccines, Inc. Targeted heterologous antigen presentation on Calicivirus virus-like particles

Similar Documents

Publication Publication Date Title
JP2017153484A5 (cg-RX-API-DMAC7.html)
WO2017015463A3 (en) Infectious disease vaccines
EP3199545A3 (en) Computationally optimized broadly reactive antigens for h1n1 influenza
JP2010227108A5 (cg-RX-API-DMAC7.html)
AU2014203512B2 (en) Recombinant virus-like particles encoded by multi-gene vector
SG11201810014UA (en) Viral particle for rna transfer, especially into cells involved in immune response
JP2015524422A5 (cg-RX-API-DMAC7.html)
WO2016046778A3 (en) Protease-activatable bispecific proteins
JP2013539454A5 (cg-RX-API-DMAC7.html)
HK1203524A1 (en) Computationally optimized broadly reactive antigens for h3n2, h2n2, and b influenza viruses
JP2013544069A5 (cg-RX-API-DMAC7.html)
WO2018053365A8 (en) METHODS OF PREPARING NUCLEIC ACID SAMPLE FOR ANALYSIS OF ACELLULAR DNA
JP2014512451A5 (cg-RX-API-DMAC7.html)
HK1203522A1 (en) Computationally optimized broadly reactive antigens for h5n1 and h1n1 influenza viruses
WO2017194902A3 (fr) Particule pour l'encapsidation d'un système d'ingénierie du génome
WO2018011599A3 (en) Process for recovering viral products using functionalised chromatography media
ZA202100386B (en) Influenza virus hemagglutinin mutants
JP2010088434A5 (cg-RX-API-DMAC7.html)
BR112015006763B1 (pt) Constructo de ácido nucleico, vetor de transferência plasmídico, partículas de vírus mv-chik, composições, uso da composição, uso das partículas de vírus mv-chik e processo para resgatar vírus do sarampo (mv) recombinante
JP2015188307A5 (cg-RX-API-DMAC7.html)
WO2012018907A3 (en) Polypeptides for treating and/or limiting influenza infection
JP2016192167A5 (cg-RX-API-DMAC7.html)
RU2017122176A (ru) Новые способы дисплея циклических пептидов на частицах бактериофага
JP2013023516A5 (cg-RX-API-DMAC7.html)
JP2016511287A5 (cg-RX-API-DMAC7.html)